Category
Cancer
Sub Category
Gynecologic
Study Name
GOG-0213: A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination With Bevacizumab (NSC #704865, IND#113912) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer
Principal Investigator
Joseph Meunier, D.O.
Study Information
Contact for Questions
517-364-2890

Site view: at a glance